1.
ROY S. COMPARATIVE EVALUATION BETWEEN QUALITY OF LIFE (QOL), ADVERSE EVENTS AND SURVIVAL ANALYSIS OF ISCADOR FOR THE TREATMENT OF SOLID TUMORS. Asian J Pharm Clin Res [Internet]. 2014 May 1 [cited 2025 Feb. 12];7(7):9-13. Available from: https://innovareacademics.in/journals/index.php/ajpcr/article/view/783